Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best single digit stocks to buy according to analysts. On January 8, Morgan Stanley lowered its price target for Rocket Pharmaceuticals from $7 to $5 while keeping an Equal Weight rating. In a 2026 group outlook, the firm noted it expects continued outperformance for US small-to-mid cap biotech as commercial companies shift from consuming capital to producing it, while large-cap biopharma faces an approaching patent cliff. In Q3 2025, Rocket Pharmac ...